TG Therapeutics Inc
NASDAQ:TGTX
Wall Street
Price Targets
TGTX Price Targets Summary
TG Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TGTX
is 31.04 USD
with a low forecast of 7.07 USD and a high forecast of 47.25 USD.
TGTX Last Price Targets
TG Therapeutics Inc
The latest public price target was made on May 3, 2024 by
Edward White
from
H.C. Wainwright
,
who expects
TGTX
stock to
rise by 203%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Edward White
H.C. Wainwright
|
49
USD
Upside 203% |
3 days ago
May 3, 2024
|
TG Therapeutics (TGTX) PT Raised to $49 at H.C. Wainwright
StreetInsider
|
|
Unknown Analyst
Cantor Fitzgerald
|
24
USD
Upside 48% |
1 year ago
Feb 7, 2023
|
Cantor Fitzgerald Maintains Overweight on TG Therapeutics, Raises Price Target to $24
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TGTX's stock price target?
Price Target
31.04
USD
According to Wall Street analysts, the average 1-year price target for
TGTX
is 31.04 USD
with a low forecast of 7.07 USD and a high forecast of 47.25 USD.
What is TG Therapeutics Inc's Revenue forecast?
Projected CAGR
37%
For the last 8 years the
compound annual growth rate for
TG Therapeutics Inc's revenue is
151%.
The projected
CAGR
for the next 3 years is
37%.
What is TG Therapeutics Inc's Operating Income forecast?
Projected CAGR
124%
The
compound annual growth rate
of TG Therapeutics Inc's operating income for the next 3 years is
124%.
What is TG Therapeutics Inc's Net Income forecast?
Projected CAGR
148%
The
compound annual growth rate
of TG Therapeutics Inc's net income for the next 3 years is
148%.
You don't have any saved screeners yet
